期刊文献+

低分子肝素皮下注射致皮下瘀斑的预防研究进展 被引量:2

Research progress on prevention of subcutaneous ecchymosis caused by subcutaneous injection of low molecular weight heparin
下载PDF
导出
摘要 低分子肝素(LMWH)首选腹部注射部位,并采用表盘注射卡轮换注射部位,匀速、缓慢注射并至少按压5 min,应用人机交互智能按压包代替人工按压的创新性干预措施,注射前或注射后冷敷3~4 min,及时关注患者感受等,可达到预防或减少皮下瘀斑的目的。但关于LMWH最佳的注射时间、按压时间以及注射部位冷敷时间仍需完善。本文阐述了LMWH在优化注射技术及创新技术应用方面的策略,综述了LMWH皮下注射致皮下瘀斑的预防研究进展。 The purpose of preventing or reducing subcutaneous ecchymosis can be achieved by selecting abdomen first,using dial injection cards to rotate injection sites,injecting low molecular weight heparin(LMWH)at a constant and slow rate and pressing for at least 5 min,using human-computer interactive intelligent pressing bags to replace innovative intervention measures of manual pressing,applying cold compress for 3 to 4 minutes before or after injection,paying attention to patients’feelings and other measures.However,the best injection time,pressing time and cold compress time of LMWH injection site still need to be improved.This paper describes the strategies of LMWH in optimizing injection technology and innovative technology application,and summarizes the research progress in prevention of subcutaneous ecchymosis caused by LMWH subcutaneous injection.
作者 徐雪蕾 刘雅菲 郭明华 郭玉颖 陈跃鑫 刘晓龙 王磊 Xu Xuelei;Liu Yafei;Guo Minghua;Guo Yuying;Chen Yuexin;Liu Xiaolong;Wang Lei(Medical Research Center Department of Vascular Surgery State Key Laboratory of Complex Severe and Rare Diseases,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100073,China)
出处 《血管与腔内血管外科杂志》 2022年第11期1348-1350,1365,共4页 Journal of Vascular and Endovascular Surgery
基金 国家自然科学基金资助项目(82170516) 中国医学科学院医学与健康科技创新工程项目(2020-I2M-C&T-B-020)。
关键词 低分子肝素 皮下注射 皮下瘀斑 low molecular weight heparin subcutaneous injection subcutaneous ecchymosis
  • 相关文献

参考文献12

二级参考文献112

共引文献393

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部